Structure

Physi-Chem Properties

Molecular Weight:  574.28
Volume:  585.873
LogP:  3.191
LogD:  2.054
LogS:  -4.046
# Rotatable Bonds:  7
TPSA:  159.82
# H-Bond Aceptor:  10
# H-Bond Donor:  4
# Rings:  3
# Heavy Atoms:  10

MedChem Properties

QED Drug-Likeness Score:  0.239
Synthetic Accessibility Score:  5.552
Fsp3:  0.581
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.532
MDCK Permeability:  8.947498281486332e-05
Pgp-inhibitor:  0.995
Pgp-substrate:  0.984
Human Intestinal Absorption (HIA):  0.674
20% Bioavailability (F20%):  0.067
30% Bioavailability (F30%):  0.985

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.464
Plasma Protein Binding (PPB):  80.19998168945312%
Volume Distribution (VD):  1.415
Pgp-substrate:  15.477429389953613%

ADMET: Metabolism

CYP1A2-inhibitor:  0.016
CYP1A2-substrate:  0.033
CYP2C19-inhibitor:  0.011
CYP2C19-substrate:  0.147
CYP2C9-inhibitor:  0.01
CYP2C9-substrate:  0.14
CYP2D6-inhibitor:  0.011
CYP2D6-substrate:  0.059
CYP3A4-inhibitor:  0.431
CYP3A4-substrate:  0.293

ADMET: Excretion

Clearance (CL):  2.474
Half-life (T1/2):  0.387

ADMET: Toxicity

hERG Blockers:  0.708
Human Hepatotoxicity (H-HT):  0.983
Drug-inuced Liver Injury (DILI):  0.714
AMES Toxicity:  0.004
Rat Oral Acute Toxicity:  0.743
Maximum Recommended Daily Dose:  0.986
Skin Sensitization:  0.171
Carcinogencity:  0.032
Eye Corrosion:  0.003
Eye Irritation:  0.014
Respiratory Toxicity:  0.977

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC311492

Natural Product ID:  NPC311492
Common Name*:   1Alpha,7Beta,13Beta,14Alpha-Tetrahydroxy-3Beta-Benzoyloxy-9Beta,15Beta-Diacetoxyjatropha-5,11 E-Diene
IUPAC Name:   [(1S,2S,3S,3aS,4R,5S,6E,9S,11R,12Z,13aS)-3a,9-diacetyloxy-3,4,5,11-tetrahydroxy-2,5,8,8,12-pentamethyl-1,2,3,4,9,10,11,13a-octahydrocyclopenta[12]annulen-1-yl] benzoate
Synonyms:  
Standard InCHIKey:  DVFBOMVAFAYEHO-IPYPLBDFSA-N
Standard InCHI:  InChI=1S/C31H42O10/c1-17-15-22-25(40-27(36)21-11-9-8-10-12-21)18(2)26(35)31(22,41-20(4)33)28(37)30(7,38)14-13-29(5,6)24(16-23(17)34)39-19(3)32/h8-15,18,22-26,28,34-35,37-38H,16H2,1-7H3/b14-13+,17-15-/t18-,22+,23-,24+,25+,26+,28-,30+,31+/m1/s1
SMILES:  C/C/1=C/[C@H]2[C@H]([C@@H](C)[C@@H]([C@@]2([C@@H]([C@](C)(/C=C/C(C)(C)[C@H](C[C@H]1O)OC(=O)C)O)O)OC(=O)C)O)OC(=O)c1ccccc1
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL400942
PubChem CID:   23642403
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids
          • [CHEMONTID:0002877] Jatrophane and cyclojatrophane diterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO31109 Pedilanthus tithymaloides Species Euphorbiaceae Eukaryota n.a. n.a. n.a. PMID[17844996]
NPO31109 Pedilanthus tithymaloides Species Euphorbiaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO31109 Pedilanthus tithymaloides Species Euphorbiaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT88 Organism Mycobacterium tuberculosis Mycobacterium tuberculosis MIC = 100.0 ug.mL-1 PMID[455255]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC311492 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9843 High Similarity NPC28836
0.9841 High Similarity NPC239358
0.9841 High Similarity NPC233692
0.9767 High Similarity NPC27721
0.9764 High Similarity NPC472248
0.9692 High Similarity NPC473301
0.969 High Similarity NPC202729
0.9685 High Similarity NPC233860
0.9612 High Similarity NPC200154
0.9254 High Similarity NPC242355
0.9225 High Similarity NPC475508
0.9118 High Similarity NPC45307
0.9111 High Similarity NPC474303
0.9111 High Similarity NPC475413
0.9023 High Similarity NPC149401
0.9023 High Similarity NPC279637
0.9023 High Similarity NPC79699
0.9 High Similarity NPC477097
0.9 High Similarity NPC477101
0.9 High Similarity NPC477099
0.8993 High Similarity NPC205389
0.8971 High Similarity NPC473497
0.8955 High Similarity NPC285221
0.8955 High Similarity NPC194769
0.8947 High Similarity NPC134937
0.8947 High Similarity NPC324898
0.8947 High Similarity NPC153617
0.8947 High Similarity NPC298547
0.8947 High Similarity NPC472250
0.8881 High Similarity NPC472247
0.8881 High Similarity NPC290833
0.8881 High Similarity NPC265459
0.8881 High Similarity NPC475262
0.8865 High Similarity NPC232583
0.8865 High Similarity NPC25484
0.8824 High Similarity NPC53361
0.8824 High Similarity NPC272523
0.8824 High Similarity NPC325805
0.8824 High Similarity NPC9905
0.8824 High Similarity NPC121268
0.8811 High Similarity NPC477098
0.8811 High Similarity NPC477100
0.8788 High Similarity NPC272946
0.8786 High Similarity NPC312393
0.8786 High Similarity NPC170668
0.8768 High Similarity NPC192658
0.8759 High Similarity NPC475660
0.8759 High Similarity NPC162613
0.8759 High Similarity NPC87934
0.875 High Similarity NPC327511
0.875 High Similarity NPC86772
0.875 High Similarity NPC205305
0.8741 High Similarity NPC232888
0.8741 High Similarity NPC477367
0.8702 High Similarity NPC472706
0.8667 High Similarity NPC477368
0.8652 High Similarity NPC478263
0.8643 High Similarity NPC34943
0.8636 High Similarity NPC472707
0.8603 High Similarity NPC270364
0.8593 High Similarity NPC477364
0.8592 High Similarity NPC327031
0.8582 High Similarity NPC25043
0.8582 High Similarity NPC134131
0.8582 High Similarity NPC478264
0.8582 High Similarity NPC311825
0.8582 High Similarity NPC92867
0.8571 High Similarity NPC477094
0.8571 High Similarity NPC477096
0.8571 High Similarity NPC153214
0.8561 High Similarity NPC187566
0.854 High Similarity NPC52523
0.854 High Similarity NPC217673
0.8529 High Similarity NPC477359
0.8521 High Similarity NPC20255
0.8521 High Similarity NPC240115
0.8493 Intermediate Similarity NPC469456
0.8489 Intermediate Similarity NPC472547
0.8472 Intermediate Similarity NPC476173
0.8451 Intermediate Similarity NPC125882
0.8444 Intermediate Similarity NPC72915
0.844 Intermediate Similarity NPC95449
0.844 Intermediate Similarity NPC82467
0.844 Intermediate Similarity NPC131966
0.844 Intermediate Similarity NPC191387
0.8429 Intermediate Similarity NPC266374
0.8429 Intermediate Similarity NPC27377
0.8429 Intermediate Similarity NPC41481
0.8429 Intermediate Similarity NPC291599
0.8429 Intermediate Similarity NPC97947
0.8429 Intermediate Similarity NPC472576
0.8429 Intermediate Similarity NPC87448
0.8429 Intermediate Similarity NPC118080
0.8417 Intermediate Similarity NPC276652
0.8414 Intermediate Similarity NPC161955
0.8397 Intermediate Similarity NPC472703
0.8392 Intermediate Similarity NPC473602
0.8392 Intermediate Similarity NPC477095
0.837 Intermediate Similarity NPC42234
0.8357 Intermediate Similarity NPC275592
0.8357 Intermediate Similarity NPC90614
0.8357 Intermediate Similarity NPC171207
0.8357 Intermediate Similarity NPC97667
0.8357 Intermediate Similarity NPC251294
0.8357 Intermediate Similarity NPC100913
0.8345 Intermediate Similarity NPC39549
0.8333 Intermediate Similarity NPC472704
0.8322 Intermediate Similarity NPC472556
0.8311 Intermediate Similarity NPC70344
0.8299 Intermediate Similarity NPC471135
0.8298 Intermediate Similarity NPC16912
0.8298 Intermediate Similarity NPC473654
0.8288 Intermediate Similarity NPC96308
0.8286 Intermediate Similarity NPC170718
0.8286 Intermediate Similarity NPC475195
0.8284 Intermediate Similarity NPC477365
0.8276 Intermediate Similarity NPC76103
0.8273 Intermediate Similarity NPC472551
0.8273 Intermediate Similarity NPC472545
0.8273 Intermediate Similarity NPC472374
0.8273 Intermediate Similarity NPC472372
0.8261 Intermediate Similarity NPC38420
0.8261 Intermediate Similarity NPC48929
0.8261 Intermediate Similarity NPC136608
0.8252 Intermediate Similarity NPC470152
0.8252 Intermediate Similarity NPC38696
0.8252 Intermediate Similarity NPC475759
0.8252 Intermediate Similarity NPC241951
0.8248 Intermediate Similarity NPC477360
0.8239 Intermediate Similarity NPC34012
0.8239 Intermediate Similarity NPC475135
0.8235 Intermediate Similarity NPC82712
0.8222 Intermediate Similarity NPC477370
0.8219 Intermediate Similarity NPC125033
0.8209 Intermediate Similarity NPC477366
0.8207 Intermediate Similarity NPC473760
0.8201 Intermediate Similarity NPC477893
0.8201 Intermediate Similarity NPC477896
0.82 Intermediate Similarity NPC476784
0.82 Intermediate Similarity NPC319404
0.8194 Intermediate Similarity NPC469349
0.8194 Intermediate Similarity NPC177940
0.8194 Intermediate Similarity NPC473088
0.8194 Intermediate Similarity NPC29704
0.8194 Intermediate Similarity NPC471104
0.8194 Intermediate Similarity NPC200471
0.8194 Intermediate Similarity NPC472572
0.8194 Intermediate Similarity NPC472575
0.8194 Intermediate Similarity NPC470159
0.8194 Intermediate Similarity NPC70403
0.8194 Intermediate Similarity NPC96903
0.8194 Intermediate Similarity NPC472568
0.8194 Intermediate Similarity NPC174982
0.8194 Intermediate Similarity NPC184817
0.8194 Intermediate Similarity NPC470157
0.8194 Intermediate Similarity NPC158663
0.8194 Intermediate Similarity NPC171525
0.8194 Intermediate Similarity NPC476973
0.8194 Intermediate Similarity NPC472571
0.8188 Intermediate Similarity NPC475548
0.8188 Intermediate Similarity NPC229354
0.8188 Intermediate Similarity NPC475638
0.8188 Intermediate Similarity NPC290683
0.8182 Intermediate Similarity NPC477894
0.8182 Intermediate Similarity NPC91703
0.8182 Intermediate Similarity NPC163087
0.8176 Intermediate Similarity NPC472658
0.8176 Intermediate Similarity NPC158546
0.8176 Intermediate Similarity NPC289021
0.8176 Intermediate Similarity NPC472657
0.8138 Intermediate Similarity NPC48599
0.8138 Intermediate Similarity NPC209592
0.8134 Intermediate Similarity NPC246166
0.8133 Intermediate Similarity NPC318447
0.8133 Intermediate Similarity NPC322048
0.8129 Intermediate Similarity NPC470143
0.8129 Intermediate Similarity NPC322503
0.8125 Intermediate Similarity NPC95265
0.8125 Intermediate Similarity NPC163719
0.8125 Intermediate Similarity NPC188865
0.8125 Intermediate Similarity NPC475122
0.8125 Intermediate Similarity NPC25768
0.8125 Intermediate Similarity NPC11685
0.8125 Intermediate Similarity NPC472573
0.8125 Intermediate Similarity NPC57628
0.8125 Intermediate Similarity NPC472569
0.8125 Intermediate Similarity NPC70716
0.8125 Intermediate Similarity NPC95810
0.8125 Intermediate Similarity NPC472570
0.8125 Intermediate Similarity NPC476974
0.8125 Intermediate Similarity NPC186296
0.8125 Intermediate Similarity NPC125106
0.8121 Intermediate Similarity NPC469730
0.8121 Intermediate Similarity NPC132599
0.8121 Intermediate Similarity NPC478235
0.8121 Intermediate Similarity NPC473632
0.8112 Intermediate Similarity NPC51181
0.8112 Intermediate Similarity NPC472546
0.8108 Intermediate Similarity NPC283875
0.8108 Intermediate Similarity NPC469647

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC311492 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8284 Intermediate Similarity NPD6007 Clinical (unspecified phase)
0.7945 Intermediate Similarity NPD7236 Approved
0.78 Intermediate Similarity NPD7239 Suspended
0.7778 Intermediate Similarity NPD6685 Approved
0.7688 Intermediate Similarity NPD7799 Discontinued
0.7589 Intermediate Similarity NPD5952 Clinical (unspecified phase)
0.7576 Intermediate Similarity NPD2629 Approved
0.7568 Intermediate Similarity NPD4628 Phase 3
0.7552 Intermediate Similarity NPD7966 Clinical (unspecified phase)
0.754 Intermediate Similarity NPD5765 Approved
0.754 Intermediate Similarity NPD5738 Clinical (unspecified phase)
0.7538 Intermediate Similarity NPD2181 Clinical (unspecified phase)
0.7483 Intermediate Similarity NPD6005 Phase 3
0.7483 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.7483 Intermediate Similarity NPD6002 Phase 3
0.7483 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.7483 Intermediate Similarity NPD6004 Phase 3
0.7481 Intermediate Similarity NPD6912 Phase 3
0.7481 Intermediate Similarity NPD7741 Discontinued
0.7448 Intermediate Similarity NPD6653 Approved
0.7444 Intermediate Similarity NPD690 Clinical (unspecified phase)
0.7394 Intermediate Similarity NPD7685 Pre-registration
0.7385 Intermediate Similarity NPD2182 Approved
0.7376 Intermediate Similarity NPD5740 Clinical (unspecified phase)
0.7376 Intermediate Similarity NPD6085 Phase 2
0.7342 Intermediate Similarity NPD7058 Phase 2
0.7342 Intermediate Similarity NPD7057 Phase 3
0.7297 Intermediate Similarity NPD7137 Phase 2
0.7266 Intermediate Similarity NPD6647 Phase 2
0.7252 Intermediate Similarity NPD6831 Clinical (unspecified phase)
0.7194 Intermediate Similarity NPD7457 Clinical (unspecified phase)
0.7133 Intermediate Similarity NPD5647 Approved
0.7132 Intermediate Similarity NPD4198 Discontinued
0.7103 Intermediate Similarity NPD7008 Discontinued
0.7101 Intermediate Similarity NPD9545 Approved
0.7097 Intermediate Similarity NPD6273 Approved
0.7077 Intermediate Similarity NPD164 Approved
0.7068 Intermediate Similarity NPD2067 Discontinued
0.7063 Intermediate Similarity NPD6362 Approved
0.7055 Intermediate Similarity NPD3764 Approved
0.7006 Intermediate Similarity NPD8470 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD5761 Phase 2
0.7 Intermediate Similarity NPD5760 Phase 2
0.6953 Remote Similarity NPD9495 Approved
0.6951 Remote Similarity NPD8127 Discontinued
0.6934 Remote Similarity NPD5951 Approved
0.6923 Remote Similarity NPD8389 Clinical (unspecified phase)
0.6913 Remote Similarity NPD6355 Discontinued
0.6913 Remote Similarity NPD230 Phase 1
0.6912 Remote Similarity NPD7094 Approved
0.6912 Remote Similarity NPD6858 Approved
0.6908 Remote Similarity NPD5762 Approved
0.6908 Remote Similarity NPD5763 Approved
0.6901 Remote Similarity NPD6287 Discontinued
0.6901 Remote Similarity NPD4806 Approved
0.6901 Remote Similarity NPD4807 Approved
0.6899 Remote Similarity NPD1238 Approved
0.6892 Remote Similarity NPD7961 Discontinued
0.6892 Remote Similarity NPD6663 Approved
0.6889 Remote Similarity NPD4141 Clinical (unspecified phase)
0.6882 Remote Similarity NPD8368 Discontinued
0.6879 Remote Similarity NPD5126 Approved
0.6879 Remote Similarity NPD8434 Phase 2
0.6879 Remote Similarity NPD5306 Approved
0.6879 Remote Similarity NPD5305 Approved
0.6879 Remote Similarity NPD5125 Phase 3
0.686 Remote Similarity NPD8407 Phase 2
0.6849 Remote Similarity NPD3663 Approved
0.6849 Remote Similarity NPD3664 Approved
0.6849 Remote Similarity NPD3661 Approved
0.6849 Remote Similarity NPD5736 Approved
0.6849 Remote Similarity NPD3662 Phase 3
0.6839 Remote Similarity NPD6190 Approved
0.6818 Remote Similarity NPD1237 Approved
0.6815 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6797 Remote Similarity NPD7702 Clinical (unspecified phase)
0.6784 Remote Similarity NPD6764 Approved
0.6784 Remote Similarity NPD6765 Approved
0.6776 Remote Similarity NPD7305 Phase 1
0.6774 Remote Similarity NPD2575 Approved
0.6774 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6768 Remote Similarity NPD7075 Discontinued
0.6767 Remote Similarity NPD5048 Discontinued
0.6761 Remote Similarity NPD3412 Clinical (unspecified phase)
0.675 Remote Similarity NPD6591 Clinical (unspecified phase)
0.6742 Remote Similarity NPD1930 Approved
0.6742 Remote Similarity NPD1929 Approved
0.6742 Remote Similarity NPD1931 Clinical (unspecified phase)
0.673 Remote Similarity NPD5403 Approved
0.6715 Remote Similarity NPD969 Suspended
0.6714 Remote Similarity NPD9493 Approved
0.6714 Remote Similarity NPD694 Clinical (unspecified phase)
0.6713 Remote Similarity NPD4136 Approved
0.6713 Remote Similarity NPD4135 Approved
0.6713 Remote Similarity NPD4106 Approved
0.6712 Remote Similarity NPD3094 Phase 2
0.6708 Remote Similarity NPD4380 Phase 2
0.6708 Remote Similarity NPD6599 Discontinued
0.6705 Remote Similarity NPD8361 Approved
0.6705 Remote Similarity NPD8360 Approved
0.6692 Remote Similarity NPD5909 Discontinued
0.6688 Remote Similarity NPD7266 Discontinued
0.6687 Remote Similarity NPD7096 Clinical (unspecified phase)
0.6686 Remote Similarity NPD8424 Clinical (unspecified phase)
0.6667 Remote Similarity NPD9258 Approved
0.6667 Remote Similarity NPD9256 Approved
0.6667 Remote Similarity NPD7033 Discontinued
0.6667 Remote Similarity NPD8166 Discontinued
0.6646 Remote Similarity NPD5402 Approved
0.6646 Remote Similarity NPD7458 Discontinued
0.6645 Remote Similarity NPD3528 Clinical (unspecified phase)
0.6643 Remote Similarity NPD7163 Clinical (unspecified phase)
0.6641 Remote Similarity NPD2066 Phase 3
0.663 Remote Similarity NPD7497 Discontinued
0.6629 Remote Similarity NPD8055 Clinical (unspecified phase)
0.6629 Remote Similarity NPD6785 Approved
0.6629 Remote Similarity NPD6784 Approved
0.6626 Remote Similarity NPD6801 Discontinued
0.6624 Remote Similarity NPD7274 Clinical (unspecified phase)
0.6622 Remote Similarity NPD5204 Approved
0.662 Remote Similarity NPD7009 Phase 2
0.6619 Remote Similarity NPD2652 Approved
0.6619 Remote Similarity NPD2650 Approved
0.661 Remote Similarity NPD8435 Approved
0.6606 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6604 Remote Similarity NPD5401 Approved
0.6603 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6591 Remote Similarity NPD8150 Discontinued
0.6589 Remote Similarity NPD1693 Approved
0.6581 Remote Similarity NPD2343 Clinical (unspecified phase)
0.6577 Remote Similarity NPD6832 Phase 2
0.6573 Remote Similarity NPD4105 Approved
0.6573 Remote Similarity NPD4102 Approved
0.6569 Remote Similarity NPD6371 Approved
0.6566 Remote Similarity NPD4381 Clinical (unspecified phase)
0.6562 Remote Similarity NPD1088 Approved
0.6561 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6561 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6561 Remote Similarity NPD4110 Phase 3
0.6556 Remote Similarity NPD7715 Approved
0.6556 Remote Similarity NPD7714 Approved
0.6549 Remote Similarity NPD7610 Discontinued
0.6541 Remote Similarity NPD6799 Approved
0.6531 Remote Similarity NPD1876 Approved
0.6525 Remote Similarity NPD7157 Approved
0.6516 Remote Similarity NPD2935 Discontinued
0.6514 Remote Similarity NPD8312 Approved
0.6514 Remote Similarity NPD8313 Approved
0.6513 Remote Similarity NPD4140 Approved
0.6512 Remote Similarity NPD5122 Clinical (unspecified phase)
0.6507 Remote Similarity NPD6637 Approved
0.6507 Remote Similarity NPD9717 Approved
0.6507 Remote Similarity NPD1608 Approved
0.65 Remote Similarity NPD2532 Approved
0.65 Remote Similarity NPD2534 Approved
0.65 Remote Similarity NPD2533 Approved
0.6494 Remote Similarity NPD2569 Approved
0.6494 Remote Similarity NPD2567 Approved
0.6486 Remote Similarity NPD2159 Approved
0.6486 Remote Similarity NPD2628 Approved
0.6486 Remote Similarity NPD2627 Approved
0.6486 Remote Similarity NPD2626 Approved
0.6486 Remote Similarity NPD2797 Approved
0.6486 Remote Similarity NPD2625 Approved
0.6486 Remote Similarity NPD2160 Approved
0.6485 Remote Similarity NPD8455 Phase 2
0.6485 Remote Similarity NPD7819 Suspended
0.6484 Remote Similarity NPD8485 Approved
0.6475 Remote Similarity NPD1609 Clinical (unspecified phase)
0.6471 Remote Similarity NPD447 Suspended
0.6471 Remote Similarity NPD5735 Approved
0.6467 Remote Similarity NPD4620 Approved
0.6467 Remote Similarity NPD5201 Approved
0.6467 Remote Similarity NPD5203 Approved
0.6467 Remote Similarity NPD4617 Approved
0.6467 Remote Similarity NPD2613 Approved
0.6456 Remote Similarity NPD7003 Approved
0.6456 Remote Similarity NPD3750 Approved
0.6456 Remote Similarity NPD7488 Clinical (unspecified phase)
0.6454 Remote Similarity NPD4766 Approved
0.6452 Remote Similarity NPD2799 Discontinued
0.6452 Remote Similarity NPD4308 Phase 3
0.645 Remote Similarity NPD7199 Phase 2
0.6449 Remote Similarity NPD4233 Approved
0.6449 Remote Similarity NPD4234 Approved
0.6447 Remote Similarity NPD6233 Phase 2
0.6442 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6438 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6438 Remote Similarity NPD3092 Approved
0.6433 Remote Similarity NPD970 Clinical (unspecified phase)
0.6424 Remote Similarity NPD7095 Approved
0.6424 Remote Similarity NPD37 Approved
0.6423 Remote Similarity NPD6406 Approved
0.6419 Remote Similarity NPD5667 Approved
0.6416 Remote Similarity NPD5844 Phase 1
0.641 Remote Similarity NPD1551 Phase 2
0.6407 Remote Similarity NPD4967 Phase 2
0.6407 Remote Similarity NPD7768 Phase 2
0.6407 Remote Similarity NPD4966 Approved
0.6407 Remote Similarity NPD4965 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data